中华医学杂志（英文版）2025，Vol.138Issue(2)：246-248,3.DOI:10.1097/CM9.0000000000003374
Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
Xin Zhang 1Xiaojuan Yu 1Suxia Wang 2Yujun Dong 3Minghui Zhao 4Fude Zhou5
作者信息
- 1. Renal Division,Department of Medicine,Peking University First Hospital,Beijing 100034,China||Institute of Nephrology,Peking University,Beijing 100034,China||Key Laboratory of Renal Disease,Ministry of Health of China,Beijing 100034,China||Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases,Chinese Academy of Medical Sciences,Beijing 100034,China
- 2. Renal Division,Department of Medicine,Peking University First Hospital,Beijing 100034,China||Institute of Nephrology,Peking University,Beijing 100034,China||Key Laboratory of Renal Disease,Ministry of Health of China,Beijing 100034,China||Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases,Chinese Academy of Medical Sciences,Beijing 100034,China||Laboratory of Electron Microscopy,Pathological Centre,Peking University First Hospital,Beijing 100034,China
- 3. Hematological Division,Department of Medicine,Peking University First Hospital,Beijing 100034,China
- 4. Renal Division,Department of Medicine,Peking University First Hospital,Beijing 100034,China||Institute of Nephrology,Peking University,Beijing 100034,China||Key Laboratory of Renal Disease,Ministry of Health of China,Beijing 100034,China||Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases,Chinese Academy of Medical Sciences,Beijing 100034,China||Peking-Tsinghua Center for Life Science,Academy for Advanced Interdisciplinary Studies,Peking University,Beijing 100034,China
- 5. Renal Division,Department of Medicine,Peking University First Hospital,Beijing 100034,China||Institute of Nephrology,Peking University,Beijing 100034,China||Key Laboratory of Renal Disease,Ministry of Health of China,Beijing 100034,China
- 折叠
引用本文复制引用
Xin Zhang,Xiaojuan Yu,Suxia Wang,Yujun Dong,Minghui Zhao,Fude Zhou..Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease[J].中华医学杂志（英文版）,2025,138(2):246-248,3.基金项目
This study was supported by grants from the National High Level Hospital Clinical Research Funding(Scientific Research Seed Fund of Peking University First Hospital)(No.2022SF37),National High Level Hospital Clinical Research Funding(No.2022CR07),National Natural Science Foundation of China(No.82070747),and CAMS Innovation Fund for Medical Sciences(No.2019-I2M-5-046). （Scientific Research Seed Fund of Peking University First Hospital）
